A Study of Using the Stoma Self-care Apps by Patients With Enterostomy

ConditionEnterostomy

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age20+

SponsorHSIN LING CHEN

About this trial

This study uses a stoma self-care app, accessed through LINE official account, a communication software commonly used by Chinese people, as an intervention measure to integrate technology acceptance and task technology adaptation models to explore the correlation of each aspect and its impact on self-care ability and quality of life. Whether the factors and task technology adaptability will affect the willingness and usage behavior of enterostomy patients, the research subjects can effectively improve their self-care ability, quality of life, usage willingness, and usage behavior after intervention.

Eligibility criteria

Qualifiers

Diagnosed with colorectal cancer or intestinal obstruction or abdominal trauma, those who have received colostomy during this hospitalization

Conscious, can communicate in Mandarin or Minnan dialect

Have no communication, vision, or hearing impairments,

Have smartphones

Disqualifiers

Those who are unable to cooperate due to visual, hearing, cognitive or mental impairments

Patients who need colostomy surgery due to non-colorectal cancer, intestinal obstruction, or abdominal trauma

Patients diagnosed by a physician as having surgery-related complications and requiring further surgery, such as infection, intestinal Perforation, stoma prolapse, stenosis, necrosis, bleeding, etc. (IV) Those who are unable to learn self-care on the day before discharge due to worsening of their illness.

Trial design

Treatments tested in this trial

stoma self-care apps
Traditional Education Receive colostomy health education manual with oral instruction

Treatment groups

50 Participants

are divided into 2 treatment groups

Sponsors and collaborators

HSIN LING CHEN

Lead sponsor

Mackay Memorial Hospital

Sponsor institution

National Taipei University of Nursing and Health Sciences

Collaborator

Source ClinicalTrials.gov